Moderna CEO defends $130 US COVID vaccine price in Senate hearing

Moderna rebuked over plan to hike COVID vaccine to $130

Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving COVID vaccine to as much as $130 per dose as soon as government stockpiles run out.

Moderna plan to hike COVID vaccine price to $130 a dose rebuked at U.S. Senate hearing - Alaska Beacon

A vaccine dose is prepared at a mass vaccination site in St. Mary’s County, Maryland, in 2021. (Maryland Executive Office of the Governor photo) WASHINGTON — The CEO of Moderna on Wednesday defended the company’s decision to drastically increase the price of its COVID-19 vaccine later this year, arguing that an expected drop in demand, changes to its distribution process and the overall benefit of the vaccine warrant the higher cost.  That decis…

Moderna rebuked over plan to hike Covid vaccine to US$130

NEW YORK, March 23 — Moderna’s chief executive yesterday defended the US company’s plan to quadruple the price of its lifesaving Covid vaccine to as much as US$130 (RM576) per dose as soon as government stockpiles run out. Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the “unprecedented level of corporate greed” in the pharmaceutical industry. “And that is certainly true with Moderna,” Sanders said. Moderna has so fa…

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics.

At Senate hearing, Bernie Sanders grills Moderna CEO for quadrupling COVID vaccine price - The Boston Globe

Moderna has previously said it will make its COVID shots freely available to anyone without insurance, but senators were skeptical about how that would work.

Moderna plan to hike COVID vaccine price to $130 a dose rebuked at U.S. Senate hearing - Wisconsin Examiner

Sen. Tammy Baldwin (D-Wis.) questions the CEO of Moderna at a hearing Wednesday about the company's planned price hike for its COVID-19 vaccine. (Screenshot | U.S. Senate video) WASHINGTON — The CEO of Moderna on Wednesday defended the company’s decision to drastically increase the price of its COVID-19 vaccine later this year, arguing that an expected drop in demand, changes to its distribution process and the overall benefit of the vaccine war…